Moreover, IFN (particularly type I IFNs) responses have recently been postulated as a central immunological axis that governs adipocyte differentiation and T cell pathogenicity during obesity-associated metabolic disease [107,108,109]. The gene discussed is IFNA1; the disease is obesity disorder.